366 results on '"Miyazaki, Masanori"'
Search Results
2. Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis
3. Development of transient [formula omitted]SR method for high-flux pulsed muons
4. Localized character of charge excitations for La$_{2-x}$Sr$_{x}$NiO$_{4+{\delta}}$ revealed by oxygen $K$-edge resonant inelastic X-ray scattering
5. Development of Ferromagnetic Fluctuations in Heavily Overdoped (Bi,Pb)_2_Sr_2_CuO_6+delta_ Copper Oxides
6. Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study
7. Quest for the Origin of Heavy Fermion Behavior in $d$-Electron Systems
8. Water-slider method reduced colonic polyp fragmentation compared with conventional suction retrieval: A prospective randomized controlled study
9. Structural anomalies and short-range magnetic correlations in the orbitally degenerated system Sr$_2$VO$_4$
10. Development of transient μSR method for high-flux pulsed muons
11. Bipartite magnetic parent phases in the iron-oxypnictide superconductor
12. Synthesis and Magnetic Properties of AxSr2−xTiO4 (A = Y, La)
13. A follow‐up questionnaire survey 2022 on radiation protection among 464 medical staff from 34 endoscopy–fluoroscopy departments in Japan
14. Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
15. Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis
16. Prediction of acoustic absorption performance of a perforated plate with air jets
17. Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers
18. Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
19. Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis
20. Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy
21. Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis.
22. Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma
23. Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma
24. Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma.
25. Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
26. Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
27. Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis
28. Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1
29. Histopathology of Neovascular Tissue From Eyes With Proliferative Diabetic Retinopathy After Intravitreal Bevacizumab Injection
30. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation
31. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin
32. Development of a pipelined data acquisition system for [formula omitted] experiments at J-PARC
33. Coexistence of superconductivity and magnetism in the Tm-based superconductor probed by muon spin relaxation
34. Effect of Zn substitution for Cu on [formula omitted] near the hole concentration of [formula omitted] per Cu
35. Development of positron detector for μSR based on multi-pixel photon counter
36. New pipelined data acquisition system for μSR experiments at J-PARC
37. Computed tomography during hepatic arteriography pattern may predict hepatocellular carcinoma recurrence following transarterial chemoembolization
38. Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection
39. Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines
40. Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
41. Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
42. Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
43. Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide
44. Preclinical long-term safety study of simian immunodeficiency virus (SIV)-based lentiviral vector for retinal gene transfer in non-human primates: OR-44.
45. Significance of liver stiffness measurement by acoustic radiation force impulse (ARFI) among hepatitis C patients
46. An early “reopening” case of idiopathic macular hole; supportive usefulness of fundus autofluorescence
47. Localized character of charge excitations for La2−xSrxNiO4+δ revealed by oxygen K -edge resonant inelastic x-ray scattering
48. Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic
49. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis
50. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: A crucial role of CD25−FOXP3− T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.